Black Bird Biotech, Inc.: 10-Q filed 2020-11-23

Name: Black Bird Biotech, Inc.: 10-Q filed 2020-11-23
Creator: Black Bird Biotech, Inc.
License: https://creativecommons.org/licenses/by/4.0/

What Black Bird Biotech, Inc. reported in its quarterly report filed 2020-11-23 (fiscal Q3 2020): 29 published measures, 92 facts as tagged in accession 0001477932-20-006838.

This filing

Form: 10-Q (quarterly report)
Filed: 2020-11-23
Fiscal period: fiscal Q3 2020
Accession: 0001477932-20-006838 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All Black Bird Biotech, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2020-09-30	112,235	USD
At 2019-12-31	973	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2020-09-30	98,305	USD
At 2019-12-31	1,141,768	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2020-09-30	13,930	USD
At 2020-06-30	42,987	USD
At 2020-03-31	47,092	USD
At 2019-12-31	-1,140,795	USD
At 2019-09-30	-1,108,078	USD
At 2019-06-30	-1,077,222	USD
At 2019-03-31	-1,048,244	USD
At 2018-12-31	-1,018,828	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2020-09-30	47,884	USD
At 2019-12-31	973	USD
At 2019-09-30	20,581	USD
At 2018-12-31	37,662	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	-229,335	USD	92
2020-01-01 to 2020-09-30	-334,484	USD	274
2019-07-01 to 2019-09-30	-36,791	USD	92
2019-01-01 to 2019-09-30	-109,059	USD	273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2020-01-01 to 2020-09-30	-303,652	USD	274
2019-01-01 to 2019-09-30	-140,187	USD	273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	20,240	USD	92
2020-01-01 to 2020-09-30	56,114	USD	274
2019-07-01 to 2019-09-30	11,122	USD	92
2019-01-01 to 2019-09-30	15,962	USD	273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2020-01-01 to 2020-09-30	266,087	USD	274
2019-01-01 to 2019-09-30	123,106	USD	273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2020-01-01 to 2020-09-30	-520	USD	274
2019-01-01 to 2019-09-30	0	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2020-09-30	-9,050,196	USD
At 2019-12-31	-8,715,712	USD

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Unit	Days
2020-07-01 to 2020-09-30	USD/shares	92
2020-01-01 to 2020-09-30	USD/shares	274
2019-07-01 to 2019-09-30	USD/shares	92
2019-01-01 to 2019-09-30	USD/shares	273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Unit	Days
2020-07-01 to 2020-09-30	USD	92
2020-01-01 to 2020-09-30	USD	274
2019-07-01 to 2019-09-30	USD	92
2019-01-01 to 2019-09-30	USD	273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	-227,286	USD	92
2020-01-01 to 2020-09-30	-332,374	USD	274
2019-07-01 to 2019-09-30	-37,091	USD	92
2019-01-01 to 2019-09-30	-109,359	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2020-09-30	111,715	USD
At 2019-12-31	973	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	2,140	USD	92
2020-01-01 to 2020-09-30	2,201	USD	274
2019-07-01 to 2019-09-30	0	USD	92
2019-01-01 to 2019-09-30	0	USD	273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2020-09-30	98,305	USD
At 2019-12-31	1,141,768	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	238,719	USD	92
2020-01-01 to 2020-09-30	366,416	USD	274
2019-07-01 to 2019-09-30	40,421	USD	92
2019-01-01 to 2019-09-30	105,183	USD	273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2020-09-30	39,370	USD
At 2019-12-31	0	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	11,433	USD	92
2020-01-01 to 2020-09-30	34,042	USD	274
2019-07-01 to 2019-09-30	3,330	USD	92
2019-01-01 to 2019-09-30	-4,176	USD	273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	8,807	USD	92
2020-01-01 to 2020-09-30	22,072	USD	274
2019-07-01 to 2019-09-30	7,792	USD	92
2019-01-01 to 2019-09-30	20,138	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2020-09-30	155,225,000	shares
At 2019-12-31	85,970,665	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2020-09-30	8,909,901	USD
At 2019-12-31	7,488,946	USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	-229,335	USD	92
2020-04-01 to 2020-06-30	-36,595	USD	91
2020-01-01 to 2020-03-31	-68,554	USD	91
2019-07-01 to 2019-09-30	-30,856	USD	92
2019-04-01 to 2019-06-30	-28,978	USD	91
2019-01-01 to 2019-03-31	-29,416	USD	90

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	14,455	USD	92
2020-01-01 to 2020-09-30	45,784	USD	274
2019-07-01 to 2019-09-30	10,831	USD	92
2019-01-01 to 2019-09-30	18,045	USD	273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	-2,049	USD	92
2020-01-01 to 2020-09-30	-2,110	USD	274
2019-07-01 to 2019-09-30	300	USD	92
2019-01-01 to 2019-09-30	300	USD	273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2020-01-01 to 2020-09-30	0	USD	274
2019-01-01 to 2019-09-30	0	USD	273

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Value	Unit	Days
2020-01-01 to 2020-09-30	0	USD	274
2019-01-01 to 2019-09-30	0	USD	273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2020-01-01 to 2020-09-30	202,500	USD	274
2019-01-01 to 2019-09-30	123,106	USD	273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2020-01-01 to 2020-09-30	-29,906	USD	274
2019-01-01 to 2019-09-30	-2,206	USD	273

Inspect the source

Entity: Black Bird Biotech, Inc. / CIK 0001409999
Captured: 2026-09-22 19:47 UTC
SEC response SHA-256: df936db10ff162447a769152b36bd1ddff9f21ac96d53dd4e87253b660581055

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001409999.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))